Johnson & Johnson JOHNSON & JOHNSON ORD (CDI)
Johnson & Johnson JOHNSON & JOHNS.../ US4781601046 /
0R34
26/04/2024 19:25:35
|
Var.
-
|
Volume |
Denaro26/04/2024 |
Lettera26/04/2024 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
146.60USD
|
-
|
7,448 Fatturato: 86,416.47 |
-Quantità in denaro: - |
-Quantità in lettera: - |
402.92 bill.USD |
2.81% |
12.06 |
Descrizione business
Johnson & Johnson and its subsidiaries (the "Company") have employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
Consiglio di amministrazione & Consiglio di sorveglianza
CEO |
Joaquin Duato |
Consiglio di amministrazione |
Joseph Wolk, Dr. Peter M. Fasolo, Dr. William N. Hait, James Swanson, Jennifer Taubert, Kathryn E. Wengel, Vanessa Broadhurst, John C. Reed, M.D., Ph.D., Liz Forminard, Tim Schmid |
Consiglio di sorveglianza |
Joaquin Duato, A. Eugene Washington, M.D., Anne M. Mulcahy, D. Scott Davis, Darius Adamczyk, Dr. Jennifer A. Doudna, Dr. Mary Beckerle, Dr. Nadja West, Hubert Joly, Marillyn A. Hewson, Mark A. Weinberger, Mark B. McClellan, Paula A. Johnson, M.D. |
Dati aziendali
Name: |
Johnson & Johnson |
Indirizzo: |
One Johnson & Johnson Plaza,,New Brunswick, New Jersey 08933, USA |
Telefono: |
+1-732-524-0400 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.jnj.com |
Industria: |
Healthcare |
Settore: |
Pharmaceutical Industry |
Sub settore: |
Pharmaceuticals |
Fine dell'anno finanziario: |
31/12 |
Flottante libero: |
77.97% |
Data dell'IPO: |
24/09/1944 |
Company calendar
CW 42 | 15/10/2024
Interim Report 3rd Quarter/9 Months
|